Targeting the Fcμ-receptor in chronic lymphocytic leukemia with a novel IgM-derived antibody-drug conjugate

Similar Items

• Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia
  od: Vire, Bérengère, i dr.
  Izdano: (2014)
• TOSO, the FcµR, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation
  od: Vire, Bérengère, i dr.
  Izdano: (2011)
• Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia
  od: Li, Fu Jun, i dr.
  Izdano: (2011)
• The Long Elusive IgM Fc Receptor, FcμR
  od: Kubagawa, Hiromi, i dr.
  Izdano: (2014)
• Identity of the elusive IgM Fc receptor (FcμR) in humans
  od: Kubagawa, Hiromi, i dr.
  Izdano: (2009)